Abstract
1. Acetylsalicylic acid (ASA; 400 mg/kg, i.p.) increased serotonin (5-HT) content in rat brain but did not modify the number or the affinity of 5-HT1A receptors in the pons and the cerebral cortex, whereas the number of cortical 5-HT2 receptors decreased significantly. 2. Pretreatment with parachlorophenylaline (100 mg/kg/day for 4 days) depleted 5-HT brain content but modified neither the serum levels of salicylates nor the 5-HT2 cortical receptor characteristics, and it abolished the antinociceptive effect of ASA, 400 mg/kg, in the first phase of the formalin test. 3. These data support the involvement of the central serotonergic system in the antinociceptive activity of ASA.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / blood
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
-
Aspirin / blood
-
Aspirin / pharmacology*
-
Brain / drug effects*
-
Brain / metabolism
-
Cerebral Cortex / drug effects
-
Cerebral Cortex / metabolism
-
Fenclonine / pharmacology
-
Formaldehyde / toxicity
-
Hindlimb
-
Male
-
Pain Measurement
-
Pons / drug effects
-
Pons / metabolism
-
Rats
-
Rats, Wistar
-
Receptors, Serotonin / drug effects
-
Receptors, Serotonin, 5-HT1
-
Serotonin / metabolism*
-
Serotonin Antagonists / pharmacology
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Receptors, Serotonin
-
Receptors, Serotonin, 5-HT1
-
Serotonin Antagonists
-
Formaldehyde
-
Serotonin
-
Aspirin
-
Fenclonine